References: [1]Location in patent: experimental part Kopylova, Lyudmila V
Psarra, A., Nikolaou, A., Kokotou, M
However, the IM route was the top-ranked statistically, followed by the SL and then the oral routes, but without clinical significance
Growth hormone receptor deficiency in Ecuador
GHK-Cu is a copper peptide complex used in controlled laboratory research models involving peptide-metal complexes, cell-culture workflows, and biochemical assay development
Composition CJC-1295 (Without DAC): 5 mg Ipamorelin: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models Assessment of assay development, including chromatographic separation of co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability